This site is for US health care professionals only.

Phenotypic precision medicine in advanced prostate cancer: a path forward

Precision medicine is an approach that utilizes diagnostic tools to select therapies for appropriate patients with the goal of optimizing outcomes and minimizing adverse events.1

Precision medicine may improve outcomes in oncology patients2; however, precision medicine is less prevalent in advanced prostate cancer compared with other tumor types.3

As treatment options for patients with advanced prostate cancer evolve,4 precision medicine may offer a more tailored approach by facilitating patient selection and helping to guide treatment decision making.5-7

Learn more:



1. Jameson J et al. In: Harrison's Principles of Internal Medicine. 20th ed. New York, NY: McGraw-Hill Education; 2018:1-20. 2. Stockley TL et al. Genome Med. 2016;8:109. 3. Friedlander TW et al. Am Soc Clin Oncol Educ Book. 2017;37:358-369. 4. Teo MY et al. Annu Rev Med. 2019;70:479-499. 5. Müller J et al. Eur J Nucl Med Mol Imaging. 2019;46(4):889-900. 6. Hofman MS et al. Lancet. 2020;395(10231):1208-1216. 7. Calais J et al. J Nucl Med. 2018;59(3):434-441.

AAA Website   |   Terms of Use   |   Privacy Policy

Advanced Accelerator Applications – A Novartis Company

© 2022 Advanced Accelerator Applications.
All Rights Reserved.